SCHEMBL22265083

SCHEMBL22265083

CC(F)(F)C(F)(F)COS(=O)(=O)c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARL Q9H300 1/20 0.39
PSIP1 O75475 1/20 0.38
HSD11B1 P28845 2/20 0.38
ALDH1A1 P00352 3/20 0.38
ATM Q13315 2/20 0.37
KMT2A Q03164 2/20 0.36
ABCC9 O60706 1/20 0.36
ABCC8 Q09428 1/20 0.36
KCNJ11 Q14654 1/20 0.36
KCNJ8 Q15842 1/20 0.36
MEN1 O00255 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
TSHR P16473 1/20 0.36
CYP2C19 P33261 1/20 0.36
TDP1 Q9NUW8 2/20 0.35
HTR6 P50406 2/20 0.35
MAPT P10636 2/20 0.35
KDM4E B2RXH2 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4138404 0.86 PARL (0.41) PARLPSIP1HSD11B1ALDH1A1KMT2A
SCHEMBL28268959 0.85 ALDH1A1 (0.41) ALDH1A1KMT2AMEN1CYP1A2CYP3A4
SCHEMBL22265082 0.84 PARL (0.40) PARLPSIP1HSD11B1ALDH1A1KMT2A
SCHEMBL3447252 0.83 PSIP1 (0.45) PARLPSIP1HSD11B1ALDH1A1ATM
SCHEMBL22265192 0.83 PARL (0.39) PARLPSIP1HSD11B1ALDH1A1KMT2A
SCHEMBL22265193 0.83 TDP1 (0.39) PARLPSIP1ALDH1A1ATMKMT2A
SCHEMBL2057595 0.82 PSIP1 (0.43) PARLPSIP1HSD11B1ALDH1A1ATM
SCHEMBL5590961 0.82 PSIP1 (0.43) PARLPSIP1HSD11B1ALDH1A1ATM
SCHEMBL2270234 0.82 CA1 (0.43) PARLPSIP1HSD11B1ALDH1A1KMT2A
SCHEMBL25402625 0.79 HSD11B1 (0.40) HSD11B1ALDH1A1KMT2AABCC9ABCC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11760737-B2 Process for manufacturing 4-(2,2,3,3-tetrafluoropropyl)morpholine ADVERIO PHARM GmbH (DE) 2023-09-19 US disclosed
US-20220089554-A1 PROCESS FOR MANUFACTURING 4-(2,2,3,3-TETRAFLUOROPROPYL)MORPHOLINE ADVERIO PHARMA GMBH (DE) 2022-03-24 US disclosed
EP-3914588-A1 PROCESS FOR MANUFACTURING 4-(2,2,3,3-TETRAFLUOROPROPYL)MORPHOLINE Adverio Pharma GmbH (DE) 2021-12-01 EP disclosed
CN-113272286-A Process for preparing 4- (2,2,3, 3-tetrafluoropropyl) morpholine 阿德弗里奥药品有限责任公司 2021-08-17 CN disclosed
WO-2020152010-A1 PROCESS FOR MANUFACTURING 4-(2,2,3,3-TETRAFLUOROPROPYL)MORPHOLINE ADVERIO PHARMA GMBH (DE) 2020-07-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220089554-A1 PROCESS FOR MANUFACTURING 4-(2,2,3,3-TETRAFLUOROPROPYL)MORPHOLINE CYP4F3, CYP4F2, TNNT2 PARL 1536/4885PSIP1 2583/4885HSD11B1 2980/4885
US-11760737-B2 Process for manufacturing 4-(2,2,3,3-tetrafluoropropyl)morpholine CYP4F3, CYP4F2, TNNT2 PARL 1536/4885PSIP1 2583/4885HSD11B1 2980/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.